State Street Corp reports 2.49% increase in ownership of HAZ / Haemonetics Corporation

Haemonetics Corporation

DE ˙ DB ˙ US4050241003

59,00 € ↑3,00 (5,36%)

2026-06-04
AKTIENPREIS

Security	DE:HAZ / Haemonetics Corporation
Institution	State Street Corp
Latest Disclosed Ownership	1,772,898 shares
Latest Disclosed Value	$ 99,920,531

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 1,772,898 shares of Haemonetics Corporation (DE:HAZ) valued at $85,099,104 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,729,847 shares of Haemonetics Corporation. This represents a change in shares of 2.49% during the quarter. The current value of the position is $104,600,982 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,772,898	43,051	2.49	99,921	-27.93	0.0034
2026-02-13	2025-12-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,729,847	-70,882	-3.94	138,647	57.97	0.0047
2025-11-14	2025-09-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,800,729	-83,254	-4.42	87,768	-37.56	0.0030
2025-08-14	2025-06-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,883,983	-34,033	-1.77	140,564	15.32	0.0053
2025-05-15	2025-03-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,918,016	-28,971	-1.49	121,890	-19.82	0.0050
2025-02-14	2024-12-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,946,987	58,494	3.10	152,021	0.15	0.0060
2024-11-14	2024-09-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,888,493	38,010	2.05	151,797	-0.84	0.0062
2024-08-14	2024-06-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,850,483	18,313	1.00	153,090	-2.10	0.0067
2024-05-15	2024-03-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,832,170	42,534	2.38	156,376	2.19	0.0070
2024-02-14	2023-12-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,789,636	48,151	2.76	153,032	-1.90	0.0074
2023-11-14	2023-09-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,741,485	-12,348	-0.70	156,002	4.47	0.0087
2023-08-14	2023-06-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,753,833	19,053	1.10	149,321	4.02	0.0078
2023-05-15	2023-03-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,734,780	42,985	2.54	143,553	7.89	0.0081
2023-05-15	2022-12-31	13F/A-99	HAEMONETICS CORP MASS	COM	405024100	1,691,795	-5,389	-0.32	133,060	5.90	0.0078
2023-05-15	2022-12-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,691,795	-5,389		133,060		0.0078
2022-11-15	2022-09-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,697,184	27,667	1.66	125,643	15.46	0.0079
2022-08-15	2022-06-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,669,517	-65,072	-3.75	108,819	-0.77	0.0065
2022-05-16	2022-03-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,734,589	43,396	2.57	109,661	22.25	0.0054
2022-02-14	2021-12-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,691,193	29,958	1.80	89,701	-23.51	0.0043
2021-11-15	2021-09-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,661,235	-13,719	-0.82	117,267	5.06	0.0062
2021-08-16	2021-06-30	13F	HAEMONETICS CORP MASS	COM	405024100	1,674,954	447,875	36.50	111,619	-18.06	0.0059
2021-07-09	2021-03-31	13F/A-1	HAEMONETICS CORP MASS	COM	405024100	1,227,079	5,826	0.48	136,218	-6.07	0.0078
2021-05-17	2021-03-31	13F	HAEMONETICS CORP MASS	COM	405024100	1,227,079	5,826		136,218		0.0078
2021-02-16	2020-12-31	13F	HAEMONETICS	COM	405024100	1,221,253	-1,016	-0.08	145,024	35.99	0.0089
2020-11-10	2020-09-30	13F	HAEMONETICS	COM	405024100	1,222,269	-37,953	-3.01	106,643	-5.51	0.0073
2020-08-14	2020-06-30	13F	HAEMONETICS	COM	405024100	1,260,222	-414,668	-24.76	112,865	-32.38	0.0082
2020-06-19	2020-03-31	13F/A-1	HAEMONETICS	COM	405024100	1,674,890	22,624	1.37	166,920	-12.08	0.0146
2020-05-11	2020-03-31	13F	HAEMONETICS	COM	405024100	1,674,890	22,624		166,920		14,658.9370
2020-02-06	2019-12-31	13F	HAEMONETICS	COM	405024100	1,652,266	-30,216	-1.80	189,845	-10.55	0.0130
2019-11-14	2019-09-30	13F	HAEMONETICS	COM	405024100	1,682,482	-40,900	-2.37	212,228	2.33	0.0158
2019-08-14	2019-06-30	13F	HAEMONETICS	COM	405024100	1,723,382	1,715	0.10	207,392	37.70	0.0155
2019-05-15	2019-03-31	13F	HAEMONETICS	COM	405024100	1,721,667	62,609	3.77	150,611	-9.26	0.0118
2019-02-12	2018-12-31	13F	HAEMONETICS	COM	405024100	1,659,058	-186,003	-10.08	165,989	-21.48	0.0151
2018-11-09	2018-09-30	13F	HAEMONETICS	Common equity shares	405024100	1,845,061	31,634	1.74	211,405	29.99	0.0162
2018-08-14	2018-06-30	13F	HAEMONETICS	Common equity shares	405024100	1,813,427	410,039	29.22	162,634	58.40	0.0136
2018-05-15	2018-03-31	13F	HAEMONETICS	Common equity shares	405024100	1,403,388	5,877	0.42	102,674	26.50	0.0087
2018-02-14	2017-12-31	13F	HAEMONETICS	Common equity shares	405024100	1,397,511	63,653	4.77	81,165	35.60	0.0065
2017-11-14	2017-09-30	13F	HAEMONETICS	Common equity shares	405024100	1,333,858	2,864	0.22	59,854	13.87	0.0052
2017-08-14	2017-06-30	13F	HAEMONETICS	Common equity shares	405024100	1,330,994	62,887	4.96	52,562	2.16	0.0046
2017-05-15	2017-03-31	13F	HAEMONETICS	Common equity shares	405024100	1,268,107	97,466	8.33	51,449	9.33	0.0046
2017-02-09	2016-12-31	13F	HAEMONETICS	Common equity shares	405024100	1,170,641	86,552	7.98	47,057	19.87	0.0044
2017-01-13	2016-09-30	13F/A-1	HAEMONETICS	Common equity shares	405024100	1,084,089	64,873	6.36	39,258	32.88	0.0040
2016-11-14	2016-09-30	13F	HAEMONETICS	Common equity shares	405024100	1,084,089			39,258
2016-08-12	2016-06-30	13F	HAEMONETICS	Common equity shares	405024100	1,019,216	-11,178	-1.08	29,544	-18.03	0.0032
2016-05-20	2016-03-31	13F/A-1	HAEMONETICS	Common equity shares	405024100	1,030,394	11,371	1.12	36,042	9.71	0.0039
2016-05-12	2016-03-31	13F	HAEMONETICS	Common equity shares	405024100	1,030,394			36,042
2016-02-16	2015-12-31	13F	HAEMONETICS	Common equity shares	405024100	1,019,023	22,859	2.29	32,853	2.04	0.0036
2015-11-16	2015-09-30	13F	HAEMONETICS	Common equity shares	405024100	996,164	-90,871	-8.36	32,196	-28.38	0.0037
2015-08-13	2015-06-30	13F	HAEMONETICS	Common equity shares	405024100	1,087,035	-49,003	-4.31	44,956	-11.91	0.0048
2015-05-15	2015-03-31	13F	HAEMONETICS	Common equity shares	405024100	1,136,038	-1,725	-0.15	51,033	19.87	0.0052
2015-02-11	2014-12-31	13F	HAEMONETICS	Common equity shares	405024100	1,137,763	-7,098	-0.62	42,574	6.48	0.0042
2014-11-12	2014-09-30	13F/A-1	HAEMONETICS	Common equity shares	405024100	1,144,861	-25,387	-2.17	39,982	-3.16	0.0043
2014-11-10	2014-09-30	13F	HAEMONETICS	Common equity shares	405024100	1,144,861			39,982
2014-08-12	2014-06-30	13F	HAEMONETICS	Common equity shares	405024100	1,170,248	-8,834	-0.75	41,285	7.43	0.0045
2014-05-15	2014-03-31	13F/A-1	HAEMONETICS	Common equity shares	405024100	1,179,082	12,859	1.10	38,428	-21.78	0.0044
2014-05-13	2014-03-31	13F	HAEMONETICS	Common equity shares	405024100	1,179,604			38,445
2014-02-06	2013-12-31	13F/A-1	HAEMONETICS	Common equity shares	405024100	1,166,223	-9,841	-0.84	49,128	4.74	0.0055
2014-02-06	2013-12-31	13F	HAEMONETICS	Common equity shares	405024100	1,153,644			47,114
2013-11-12	2013-09-30	13F	HAEMONETICS	Common equity shares	405024100	1,176,064	1,606	0.14	46,903	-3.42	0.0058
2013-08-08	2013-06-30	13F	HAEMONETICS	Common equity shares	405024100	1,174,458	1,174,458		48,565		0.0063

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.